LPC Pharma To Outsource Pharmacovigilance/Drug Safety To APCER

Published: 08-Feb-2010

APCER Pharma has announced that LPC Pharma is outsourcing its pharmacovigilance/drug safety operations to the company.

Satnam Butter, director of LPC, said: “APCER uses best in class, validated processes and technology. Their staff have excellent training and qualifications. Outsourcing our pharmacovigilance operations to the experts at APCER allows LPC to focus our resources on our areas of expertise.”

Michael Reynolds, head of sales and marketing for Europe, Asia and Africa at APCER, said: “We’re delighted to be working with LPC. Maintaining the system is one of the most expensive, time-consuming burdens facing a pharmaceutical company. APCER is 100% committed to our customers’ successes. We maintain continuous contact through visits and regular updates, which enables smooth and efficient implementations. Our team becomes an extension of every client’s operation.”

APCER is a global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

LPC, based in Luton, specialises in the supply of branded and generic medicines across the UK. It owns the intellectual property for over 150 licences enabling supply of own label and several brands, such as Uvistat sun cream, Dalivit Multivitamin Drops and Hill’s Balsam for chesty and dry cough.

No items to display

Tell your friend about this article